查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1606321

细胞讯号市场：按产品类型、最终用途划分 - 2025-2030 年全球预测

Cell Signaling Market by Product (Consumables, Instruments), Type (Autocrine Signaling, Endocrine Signaling, Juxtacrine Signaling), End-use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年细胞讯号市值为38.8亿美元，预计2024年将达到41.2亿美元，复合年增长率为6.57%，到2030年将达到60.6亿美元。

细胞讯号传导是控制细胞功能和命运的复杂通讯网络，对于理解各种生物过程和疾病至关重要。细胞讯号传导的范围跨越肿瘤学、免疫学和神经学等多个领域。细胞讯号传导研究的需求在于阐明健康和疾病背后的复杂机制的潜力，从而促进治疗方法和诊断的进步。最终用途广泛，包括製药、生物技术和学术研究，并对药物发现、个人化医疗和新疗法的开发产生重大影响。

主要市场统计
基准年[2023] 38.8亿美元
预计年份 [2024] 41.2亿美元
预测年份 [2030] 60.6亿美元
复合年增长率（%） 6.57%

推动市场成长的主要因素是慢性病的增加、分子生物学的技术进步、以及生命科学研究资金的增加。标靶治疗和精准医疗的发展机会庞大，重组DNA技术和生物资讯学将发挥重要作用。利用这些机会的建议包括投资于药物开发的合作研究和伙伴关係、加强生物资讯能力以及专注于医疗基础设施快速发展的新兴经济体。然而，市场开拓面临高昂的研发成本、严格的监管要求以及生物系统的复杂性等限制，减缓了产品的开发和商业化。

创新研究领域包括新型讯号路径的研究、CRISPR 基因编辑在疾病模型中的应用以及单细胞分析技术的进步。对非编码 RNA 及其在细胞讯号传导中的调节作用的研究为突破性治疗方法提供了令人兴奋的可能性。从市场角度来看，公司必须利用资料分析和机器学习来保持敏捷性，以获得对讯号路径和疾病结果的预测性见解。儘管该市场具有强劲的成长潜力，但企业可以透过采取适应性策略和促进跨学科合作来克服挑战，以确保细胞讯号研究及其应用的持续成长。

市场动态：揭示快速发展的细胞讯号市场的关键市场洞察

供需的动态交互作用正在改变细胞讯号市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 生物医学研究活动的需求增加
    • 政府支持细胞研究和治疗的倡议
    • 扩大细胞讯号传导在药物发现和药物开发的应用
  • 市场限制因素
    • 与讯号转导途径和试剂开发相关的复杂性
  • 市场机会
    • 细胞讯号技术和工具的不断进步
    • 增加对干细胞研究活动的投资
  • 市场挑战
    • 与细胞讯号传导相关的伦理问题和监管限制

波特五力：驾驭细胞讯号市场的策略工具

波特的五力架构是了解细胞讯号传导市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解细胞讯号市场的外部影响

外部宏观环境因素在塑造细胞讯号市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解细胞讯号传导市场的竞争格局

对细胞讯号市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵细胞讯号市场供应商绩效评估

FPNV定位矩阵是评估细胞讯号市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

制定细胞讯号市场成功之路的策略分析与建议

对于旨在加强在全球市场的影响力的公司来说，细胞讯号市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 对生物医学研究活动的需求增加
      • 政府支持细胞研究和治疗的努力
      • 扩大细胞讯号传导在药物发现与开发的应用
    • 抑制因素
      • 与讯号转导途径和试剂开发相关的复杂性
    • 机会
      • 细胞讯号传导技术和工具的不断进步
      • 增加对干细胞研究活动的投资
    • 任务
      • 与细胞讯号传导相关的伦理问题和监管限制
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章细胞讯号市场：副产品

  • 消耗品
  • 装置

第七章细胞讯号市场：依类型

  • 自分泌讯号
  • 内分泌讯号
  • 近分泌讯号传导
  • 旁分泌讯号传导

第 8 章 细胞讯号市场：依最终用途分类

  • 学术/研究机构
  • 医药及生物製药产业

第九章美洲细胞讯号市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太细胞讯号市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的细胞讯号市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abcam PLC
  • Beckman Coulter, Inc. by Danaher Corporation
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • BPS Bioscience, Inc.
  • Cell Biolabs, Inc.
  • Cell Signaling Technology, Inc.
  • Full Moon BioSystems, Inc.
  • Merck KGaA
  • Miltenyi Biotec BV & Co. KG
  • PerkinElmer Inc.
  • Promega Corporation
  • QIAGEN NV
  • RayBiotech Life, Inc.
  • Rockland Immunochemicals, Inc.
  • Santa Cruz Biotechnology, Inc.
  • Sino Biological, Inc.
  • StressMarq Biosciences Inc.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-007C484E5E63

The Cell Signaling Market was valued at USD 3.88 billion in 2023, expected to reach USD 4.12 billion in 2024, and is projected to grow at a CAGR of 6.57%, to USD 6.06 billion by 2030.

Cell signaling, the intricate communication network that governs cellular function and fate, is crucial for understanding various biological processes and diseases. The scope of cell signaling spans multiple domains, including oncology, immunology, and neurology. The necessity of cell signaling research lies in its potential to unravel complex mechanisms underlying health and disease, thereby driving advancements in therapeutics and diagnostics. End-use applications are diverse, stretching across pharmaceuticals, biotechnology, and academic research, with significant implications for drug discovery, personalized medicine, and the development of novel therapeutics.

KEY MARKET STATISTICS
Base Year [2023] USD 3.88 billion
Estimated Year [2024] USD 4.12 billion
Forecast Year [2030] USD 6.06 billion
CAGR (%) 6.57%

Market growth is primarily influenced by rising incidences of chronic diseases, technological advancements in molecular biology, and increasing funding for life sciences research. Opportunities abound in the development of targeted therapies and precision medicine, with recombinant DNA technology and bioinformatics playing key roles. Recommendations to capitalize on these opportunities include investing in collaborations and partnerships for drug development, enhancing bioinformatics capabilities, and focusing on emerging economies where healthcare infrastructure is rapidly developing. However, market growth faces limitations such as high research and development costs, stringent regulatory requirements, and the complexity of biological systems that can delay product development and commercialization.

Innovation areas ripe for exploration include the study of novel signaling pathways, the application of CRISPR for gene editing in disease models, and advancements in single-cell analysis technologies. Research into non-coding RNAs and their regulatory roles in cell signaling presents intriguing potential for groundbreaking therapies. From a market perspective, it is essential for businesses to stay agile, leveraging data analytics and machine learning to derive predictive insights into signaling pathways and disease outcomes. While the market is characterized by robust growth potential, companies need to navigate challenges by adopting adaptive strategies and fostering multidisciplinary collaborations to ensure sustainable advancement in cell signaling research and its applications.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cell Signaling Market

The Cell Signaling Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing demand in biomedical research activities
    • Government initiatives supporting cell-based research and therapies
    • Growing application of cell signaling in drug discovery and development
  • Market Restraints
    • Complexities associated with signaling pathways and reagent development
  • Market Opportunities
    • Ongoing advancements in cell signaling techniques and tools
    • Rising investment in stem cell research activities
  • Market Challenges
    • Ethical issues and regulatory constraints associated with cell signaling

Porter's Five Forces: A Strategic Tool for Navigating the Cell Signaling Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cell Signaling Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cell Signaling Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cell Signaling Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cell Signaling Market

A detailed market share analysis in the Cell Signaling Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cell Signaling Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cell Signaling Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cell Signaling Market

A strategic analysis of the Cell Signaling Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cell Signaling Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Beckman Coulter, Inc. by Danaher Corporation, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, BPS Bioscience, Inc., Cell Biolabs, Inc., Cell Signaling Technology, Inc., Full Moon BioSystems, Inc., Merck KGaA, Miltenyi Biotec B.V. & Co. KG, PerkinElmer Inc., Promega Corporation, QIAGEN N.V., RayBiotech Life, Inc., Rockland Immunochemicals, Inc., Santa Cruz Biotechnology, Inc., Sino Biological, Inc., StressMarq Biosciences Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Cell Signaling Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Consumables and Instruments.
  • Based on Type, market is studied across Autocrine Signaling, Endocrine Signaling, Juxtacrine Signaling, and Paracrine Signaling.
  • Based on End-use, market is studied across Academic & Research Institutions and Pharmaceutical & Biopharmaceutical Industries.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing demand in biomedical research activities
      • 5.1.1.2. Government initiatives supporting cell-based research and therapies
      • 5.1.1.3. Growing application of cell signaling in drug discovery and development
    • 5.1.2. Restraints
      • 5.1.2.1. Complexities associated with signaling pathways and reagent development
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advancements in cell signaling techniques and tools
      • 5.1.3.2. Rising investment in stem cell research activities
    • 5.1.4. Challenges
      • 5.1.4.1. Ethical issues and regulatory constraints associated with cell signaling
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cell Signaling Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Instruments

7. Cell Signaling Market, by Type

  • 7.1. Introduction
  • 7.2. Autocrine Signaling
  • 7.3. Endocrine Signaling
  • 7.4. Juxtacrine Signaling
  • 7.5. Paracrine Signaling

8. Cell Signaling Market, by End-use

  • 8.1. Introduction
  • 8.2. Academic & Research Institutions
  • 8.3. Pharmaceutical & Biopharmaceutical Industries

9. Americas Cell Signaling Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cell Signaling Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cell Signaling Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abcam PLC
  • 2. Beckman Coulter, Inc. by Danaher Corporation
  • 3. Becton, Dickinson and Company
  • 4. Bio-Rad Laboratories, Inc.
  • 5. Bio-Techne Corporation
  • 6. BPS Bioscience, Inc.
  • 7. Cell Biolabs, Inc.
  • 8. Cell Signaling Technology, Inc.
  • 9. Full Moon BioSystems, Inc.
  • 10. Merck KGaA
  • 11. Miltenyi Biotec B.V. & Co. KG
  • 12. PerkinElmer Inc.
  • 13. Promega Corporation
  • 14. QIAGEN N.V.
  • 15. RayBiotech Life, Inc.
  • 16. Rockland Immunochemicals, Inc.
  • 17. Santa Cruz Biotechnology, Inc.
  • 18. Sino Biological, Inc.
  • 19. StressMarq Biosciences Inc.
  • 20. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. CELL SIGNALING MARKET RESEARCH PROCESS
  • FIGURE 2. CELL SIGNALING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CELL SIGNALING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CELL SIGNALING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CELL SIGNALING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CELL SIGNALING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CELL SIGNALING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CELL SIGNALING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CELL SIGNALING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CELL SIGNALING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CELL SIGNALING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS CELL SIGNALING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS CELL SIGNALING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES CELL SIGNALING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES CELL SIGNALING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CELL SIGNALING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC CELL SIGNALING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CELL SIGNALING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CELL SIGNALING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. CELL SIGNALING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. CELL SIGNALING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CELL SIGNALING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CELL SIGNALING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CELL SIGNALING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CELL SIGNALING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CELL SIGNALING MARKET DYNAMICS
  • TABLE 7. GLOBAL CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CELL SIGNALING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CELL SIGNALING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CELL SIGNALING MARKET SIZE, BY AUTOCRINE SIGNALING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CELL SIGNALING MARKET SIZE, BY ENDOCRINE SIGNALING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CELL SIGNALING MARKET SIZE, BY JUXTACRINE SIGNALING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CELL SIGNALING MARKET SIZE, BY PARACRINE SIGNALING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CELL SIGNALING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CELL SIGNALING MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL INDUSTRIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS CELL SIGNALING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES CELL SIGNALING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC CELL SIGNALING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA CELL SIGNALING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 145. CELL SIGNALING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. CELL SIGNALING MARKET, FPNV POSITIONING MATRIX, 2023